Академический Документы
Профессиональный Документы
Культура Документы
References
1 World Health Organization. Guidelines for the programmatic
management of drug-resistant tuberculosis. Emergency update
2008. WHO/HTM/TB/2008.402. Geneva, Switzerland: WHO,
2008. http://whqlibdoc.who.int/publications/2008/9789241547
581_eng.pdf Accessed June 2013.
2 Caminero J A, ed. Guidelines for clinical and operational management of drug-resistant tuberculosis. Paris, France: International Union Against Tuberculosis and Lung Disease, 2013.
3 World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland:
WHO, 2009. http://whqlibdoc.who.int/publications/2010/9789
241547833_eng.pdf Accessed June 2013.
4 Bojorquez-Chapela I, Bcker C E, Orejel I, et al. Drug resistance
in Mexico: results from the National Survey on Drug-Resistant
Tuberculosis. Int J Tuberc Lung Dis 2013; 17: 514519.
5 Granich R M, Balandrano S, Santaella A J, et al. Survey of drug
resistance of Mycobacterium tuberculosis in 3 Mexican states,
1997. Arch Intern Med 2000; 160: 639644.
6 Blumberg H M, Burman W J, Chaisson R E, et al. American
Thoracic Society/Centers for Disease Control and Prevention/
Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603662.
1245
Acknowledgements
The authors acknowledge the assistance of N Nina, Licenciada R
Casillo and J Melgarejo and other staff at the collaborating centres
and the patients who took part in this study. They also thank the
London School of Hygiene & Tropical Medicine Trust Funds for financing travel to Bolivia to carry out field research for this project.
1246
References
1 World Bank. World development indicatorsBolivia, 2012.
Washington, DC, USA: World Bank. http://www.worldbank.
org/en/country/bolivia Accessed June 2013.
2 World Health Organization. Global tuberculosis control, 2012.
WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
3 Salaniponi F M L, Harries A D, Banda H T, et al. Care seeking
behaviour and diagnostic processes in patients with smear-positive
ERRATUM
IN THE ARTICLE entitled Waterpipe smoking: prevalence and attitudes among medical students in
London by M. Jawad, J. Abass, A. Hariri, K. G. Rajasooriar, H. Salmasi, C. Millett, F. L. Hamilton (Int J
Tuberc Lung Dis 2013; 17(1): 137140; http://dx.doi.org/10.5588/ijtld.12.0175), an error occurred in
the labelling of the last three lines of Table 2. It should have read as follows:
OR (95%CI)
P value
Prevalence:
ever
%
1.0
6.90 (2.9216.30)
14.85 (3.3565.89)
<0.01
<0.01
4.4
84.3
93.5
Smoking status
Never
Former
Current
OR (95%CI)
P value
Prevalence:
current
%
1.0
0.76 (0.222.67)
5.16 (1.9213.87)
<0.67
<0.01
9.6
9.8
32.3
[http://dx.doi.org/10.5588/ijtld.12.0175-e]